Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis
Authors:
- Lorenzo GaetaniLGLorenzo Gaetani
- Marinella Di CarloMCMarinella Di Carlo
- Giovanni BrachelenteGBGiovanni Brachelente
- Federico VallettaFVFederico Valletta
- Paolo EusebiPEPaolo Eusebi
- Andrea ManciniAMAndrea Mancini
- Lucia GentiliLGLucia Gentili
- Angela BorrelliABAngela Borrelli
- Paolo CalabresiPCPaolo Calabresi
- Paola SarchielliPSPaola Sarchielli
- Carla FerriCFCarla Ferri
- Alfredo VillaAVAlfredo Villa
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 339, 577108
Abstract
No abstract availableKeywords
Funding Information
- Bayer
- Boehringer Ingelheim
This publication has 26 references indexed in Scilit:
- Intrathecal oligoclonal IgG synthesis in multiple sclerosisJournal of Neuroimmunology, 2013
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingNeurology, 2009
- Incidental MRI anomalies suggestive of multiple sclerosisNeurology, 2009
- Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosisJournal of Neurology, 2008
- Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task forceEuropean Journal of Neurology, 2006
- Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Multiple sclerosisNeurology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Oligoclonal IgG and Free Light Chains in the Cerebrospinal Fluid of Patients with Multiple Sclerosis and Infectious Diseases of the Central Nervous SystemScandinavian Journal of Immunology, 1977